Impax Laboratories (IPXL) PT Lowered to $17 at Cowen Following Announced Deal with Amneal
Tweet Send to a Friend
Cowen lowered its price target on Impax Laboratories (NASDAQ: IPXL) to $17.00 (from $20.00) while maintaining a Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
